Sanara is an independent UK information and comparison service. Links marked * lead to external providers. Affiliate tracking is not active and Sanara earns no commission from these links.Independent UK comparison. We earn no commission from provider links. Learn more

The peptide library / Buying safely

Licensed and research peptides: UK access

The differences between authorised medicines, unlicensed clinical supply, cosmetics and research-only peptide materials.

5 minute readUpdated View sources

The short answer

A research-use peptide is not an authorised medicine. “Research use only” describes a laboratory purpose; it does not demonstrate safety for people. UK medicine status and lawful supply depend on the particular product, its claims and the applicable regulatory pathway.

A product licence and a test report answer different questions

A medicinal product authorisation relates to a defined product and its authorised uses. A certificate of analysis reports specified tests on a sample. Neither a seller’s reviews nor the existence of a chemical test should be presented as a medicine licence.

Ask for the product name, authorisation details where applicable, patient information and the identity of the dispensing pharmacy. Check information with the regulator independently rather than relying only on a badge displayed by a retailer.

Sources: MHRA: how products are classified as medicines · GPhC: staying safe when getting treatment online

What a research-use label can and cannot tell you

Laboratory reagents may be designed for analytical work, cell studies or other research. Their specification may be entirely appropriate for that purpose while saying nothing about suitability as a patient treatment. Buying a vial does not create a clinical care pathway.

Do not assume that a familiar molecule is interchangeable across a lab powder, a cosmetic and a medicine. Excipients, packaging, stability, contamination controls and the intended route can change the relevant risks. This library does not provide preparation, dosing or self-administration protocols for research materials.

What about unlicensed medicines?

UK guidance describes circumstances in which an unlicensed medicine may meet an individual patient’s special clinical need. Appropriate prescribing and authorised supply remain essential. A clinician’s involvement does not automatically validate every commercial claim made about a product.

If an unlicensed product is proposed in clinical care, ask why an authorised alternative cannot meet your need, what evidence supports the choice, what uncertainties remain and how you will be monitored. Keep those answers separate from a salesperson’s promises.

Sources: MHRA: supply of unlicensed medicinal products

Questions for an online provider

A transparent service should make it easy to establish who takes responsibility before you disclose medical information or make a payment. A registered pharmacy and a clinician have different roles; verify both where relevant.

  • Who assesses suitability, and how can their professional registration be checked?
  • Which pharmacy dispenses, and does its registered address match the information supplied?
  • What happens if treatment is declined, unsuitable or unavailable?
  • Who handles side effects, follow-up and urgent concerns?
  • What are the full costs of assessment, supply, reviews and delivery?

Sources: GPhC: staying safe when getting treatment online

Read claims in their proper context

“Available online”, “UK dispatch”, “high purity” and “third-party tested” are different statements. None alone means that a product is licensed for a health condition. A UK delivery address establishes logistics, not regulatory approval.

Keep copies of relevant pages and ask for written clarification where a website mixes laboratory labels with personal health promises. If you cannot determine the product category, pause the purchase and seek advice from a pharmacist or the relevant regulator.

Sources: MHRA: advertising medicines in the UK

Common questions

Does “research use only” make a peptide safe to use?

No. It describes a research purpose and does not establish suitability for human use.

Is an unlicensed medicine always illegal?

No. Defined clinical supply routes exist for particular patient needs. That is different from unrestricted public sale or advertising.

Does UK dispatch mean UK approval?

No. Dispatch location and regulatory status are separate checks.

Sources & editorial note

AI-assisted editorial research prepared for Sanara Health on 8 September 2026. This page has not been clinically reviewed and does not provide a personal treatment recommendation. Product and regulatory information can change.

  1. MHRA: how products are classified as medicines
  2. GPhC: staying safe when getting treatment online
  3. MHRA: supply of unlicensed medicinal products
  4. MHRA: advertising medicines in the UK

Our editorial policy · Suggest a correction

Continue exploring